Correction: Surgical Management of Young Women with High-Risk Breast Cancer Receiving Neoadjuvant Systemic Therapy on the I-SPY2 Trial
Year: 2026
Type: erratum
Source: Annals of Surgical Oncology
Authors: J. Tseng, K. Dimitroff, C. A. M. Sauder, A. J. Chien, K. A. Ahmed, L. F. Allen, C. A. Arciero, E. E. Burke, J. M. Chandler, J. E. Jordan, M. Golshan, L. A. Gutnik, N. T. Jaskowiak, K. C. Hewitt, M. Howard-McNatt, F. Ito, I. M. Kang, S. B. Kesmodel, H. M. Kuerer, M. C. Lee, M. S. Moran, L. M. Postlewait, N. D. Prionas, R. Rao, C. R. Reyna, A. Schwer, N. K. Taunk, J. Tchou, A. M. Wallace, T. J. Li, J. Perlmutter, A. M. DeMichele, D. Yee, N. M. Hylton, L. J. van’t Veer, H. S. Rugo, W. F. Symmans, R. A. Shatsky, C. J. D. Isaacs, C. Yau, L. J. Esserman, J. C. Boughey, R. A. Mukhtar
Institutions: City of Hope, Quantum Leap Healthcare Collaborative, University of California, Davis, University of California, San Francisco, Moffitt Cancer Center, Atrium Health Wake Forest Baptist, Emory University, Ohio State University Hospital, The Ohio State University, Yale University, University of Alabama at Birmingham, University of Chicago, University of Utah, University of Southern California, University of Miami Hospital, The University of Texas MD Anderson Cancer Center, Columbia University Irving Medical Center, Loyola University Medical Center, University of Pennsylvania, University of California San Diego, University of Minnesota, City Of Hope National Medical Center, Georgetown University, Mayo Clinic
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $4,590
OpenAlex ID: W7207674642